Lantern Pharma Inc. announced that Leslie W. Kreis, Jr., the Managing Principal at Steelhead Capital Management, LLC, managing partner and co-founder of Bios Equity Partners, LP and Bios Equity Partners II, LP, and a member of Lantern Pharma's Board of Directors since 2019, has advised Lantern's Board of his determination not to stand for reelection as a Director at Lantern's Annual Meeting.